Experimental & Clinical Neuro-Oncology (Neuro-Oncology Parallel Session)
Tracks
Room 3
| Tuesday, September 26, 2023 |
| 8:30 AM - 10:00 AM |
| Room 3 |
Details
Oral Presentations duration (each): 7 minutes + 1 minute Q&A
Speakers & Chairs
Dr Marike Broekman
Neurosurgeon
Haaglanden Medical Center And Leiden University Medical Center
Chair
Dr Janez Ravnik
Head Of Department Of Neurosurgery
University Medical Centre Maribor, Slovenia
Chair
Prof Johnny Duerinck
Chief Of Clinic
UZ Brussel
Strategies to improve immunogenicity of glioblastoma - role of the neurosurgeon
8:30 AM - 8:40 AM
Prof. Pim J French
Pi
Erasmus Medical Center
Molecular evolution of glioblastoma and tumor recurrence
8:40 AM - 8:50 AM
Prof Ihsan Solaroglu
Neurosurgen
Koç University
Maximal Safe Resection in Glioma Surgery: the “gold standard” with prolonged survival
8:50 AM - 9:00 AM
Dr Obada Alhalabi
Resident
Heidelberg University Hospital
Resection of Recurrent Intracranial Tumors for Molecular Diagnostics in the Age of Precision Oncology: A Risk-Benefit Analysis
Dr Christine Jungk
Senior Consultant
University Hospital Heidelberg
Prognostic Impact of Extended Resections in IDH Mutant Lower-Grade Diffuse Glioma: Results from a Volumetric Analysis
Dr Christine Jungk
Senior Consultant
University Hospital Heidelberg
Subventricular Zone Involvement in IDH Mutant Lower-Grade Glioma: Impact on Treatment and Patient Outcome
Dr Vera Nickl
Resident
Universität Würzburg
CAR-T Cells Against Three Novel Antigens Show Antitumoral Efficacy in Ex Vivo Patient Derived Glioblastoma Organoids
Dr Rebeca Pérez Alfayate
Department of Neurosurgery Faculty
Hospital Clínico San Carlos
ctDNA Detection In Cerebrospinal Fluid And Concordance With The Primary Tumor in a Multicenter Prospective Study Of Patients With Glioma
Prof Constantin Roder
Board Certified Neurosurgeon
University of Tuebingen
Intraoperative MRI-guided resection compared to 5-ALA-guidance in newly diagnosed glioblastoma: A prospective controlled multicenter clinical trial
Dr Vittorio Stumpo
Resident
University Hospital Zurich
Glioblastoma tissue invasion mapping with novel hypoxia-targeted blood oxygenation-level dependent MRI
